Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3394 Target Snapshot

Tubulin beta chain · SINGLE PROTEIN · Bos taurus

360Compounds
34Assays
3Approved Drugs
269.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q6B856. Use UniProt Q6B856 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q6B856 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Tubulin beta chain as ChEMBL target CHEMBL3394, mapped to UniProt Q6B856. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Tubulin beta chain
SINGLE PROTEIN · Bos taurus
As of 2026-09-14
ChEMBL target ID
CHEMBL3394
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q6B856
Tubulin beta-2B chain
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Tubulin beta chain is the right protein anchor across sources, using UniProt Q6B856 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelTubulin beta-2B chain
UniProt AccessionQ6B856
Component TypeProtein
Sequence Length445 aa

Tubulin beta-2B chain

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Tubulin beta chain, mapped to UniProt Q6B856. ChEMBL maps the protein component as Tubulin beta-2B chain. Sequence length is 445 aa.

Mapped IDQ6B856
Review nameTubulin beta chain
OrganismBos taurus
Clinical Profile

Clinical Phase Distribution

3
Approved
2
Phase II
Assay Mix

Activity Type Distribution

IC50259.0
KI10.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL67 6.75 Ki 180.0 Preclinical
CHEMBL343288 6.41 IC50 390.0 Preclinical
CHEMBL61 6.34 IC50 460.0 Approved
CHEMBL140220 6.28 IC50 530.0 Preclinical
CHEMBL140363 6.28 IC50 530.0 Preclinical
CHEMBL67 6.28 IC50 530.0 Preclinical
CHEMBL279142 6.24 IC50 570.0 Preclinical
CHEMBL14120 6.21 IC50 610.0 Preclinical
CHEMBL14782 6.21 IC50 620.0 Preclinical
CHEMBL73156 6.21 IC50 620.0 Preclinical
Distribution

pChEMBL Value Distribution

55
5.0
69
5.5
44
6.0
1
6.5
0
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

PODOFILOX
CHEMBL61
Approved 1990
COLCHICINE
CHEMBL107
Approved 1961
Assay Landscape

Assay Landscape

34
Total Assays
140
Tested Compounds
2
Assay Types
Binding — 24 assays, 60 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 14 37 5.3
assay format 9 18 5.2
tissue-based format 1 5 5.3
Functional — 10 assays, 140 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 10 140 5.6

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine